Lidocaine Wound Gel, 0.13% recall — Water-jel Technologies, LLC (Class III)

Water-jel Technologies, LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%) — a Class III recall, initiated 2026-04-07 and posted to the FDA enforcement report on 2026-05-06, under recall number D-0509-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Failed PH Specifications”. From the product description, the form is gel and the strengths given are 0.13%, 2% and 14 g. Distribution is recorded as “Nationwide in the USA” — Nationwide (US), with the recalling firm on record in NC, United States. It is the only recall number the FDA has filed under event ID 98737. 29 days separate the firm's initiation date from the FDA's report date on this record. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0509-2026
FDA event ID 98737
Classification Class III (least serious regulatory tier)
Status Ongoing
Recalling firm Water-jel Technologies, LLC
Recall initiated 2026-04-07
Reported by FDA 2026-05-06
Report lag 29 days from initiation to report
Distribution Nationwide in the USA — Nationwide (US)
Firm location on record NC, United States
Product description (source) Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

Reason reported by FDA

Failed PH Specifications

3 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

5 identifying values matched by exact pattern in the 29-word product description above; each is a literal substring of it.

Product named Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%)
Form Gel
Strength 0.13% · 2% · 14 g
Distributed by CVS PHarmacy, INc.

Reported in the same month (2026-05)

48 enforcement reports carry a report date in 2026-05; these 8 are the Class III ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Levocarnitine Injection, 1 g/5 mLD-0494-2026American Regent, Inc.Class III2026-05-06
busPIRone Hydrochloride Tablets, 5 mgD-0511-2026Unichem Pharmaceuticals Usa Inc.Class III2026-05-13
Primidone Tablets USP, 250mgD-0533-2026Lannett Company Inc.Class III2026-05-27
Primidone Tablets, 50 mgD-0534-2026Golden State Medical Supply Inc.Class III2026-05-27
Primidone Tablets, 250 mgD-0535-2026Golden State Medical Supply Inc.Class III2026-05-27
Primidone Tablets, 250 mgD-0536-2026Amerisource Health Services LLCClass III2026-05-27
Primidone Tablets, 50 mgD-0537-2026Amerisource Health Services LLCClass III2026-05-27
Busulfan Injection, 60 mgD-0539-2026Sagent PharmaceuticalsClass III2026-05-27

Nearest Class III recalls by date

25 of 250 indexed records share the Class III tier; the 8 nearest to 2026-05-06 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Premier, 8 mLD-0490-2026Premier Dental Products Co8 mL · Solution2026-04-29
Nicotine Transdermal System Patch, 14 mgD-0550-2026Aveva Drug Delivery Systems, Inc.14 mg · Transdermal System2026-06-03
PRED MILD, 0.12%D-0551-2026Abbvie Inc.0.12% · Ophthalmic Suspension2026-06-03
Lidocaine HCl Injection, 2%D-0552-2026Eugia US LLC2% · Injection2026-06-10
Epinephrine Injection, 1mg/mLD-0581-2026Fresenius Kabi Usa, LLC1mg/mL · Injection2026-06-17
Primidone Tablets, 50 mgD-0585-2026Amneal Pharmaceuticals, LLC50 mg · Tablets2026-06-17
Focalin XR (dexmethylphenidate HCl) 5 mgD-0608-2026Sandoz Inc5 mg · Extended-Release Capsules2026-06-24
hydrOXYzine Hydrochloride Oral Solution, 10 mg/5 mLD-0619-2026Ani Pharmaceuticals, Inc.10 mg/5 mL · Oral Solution2026-07-01

Reading this record

Class III is the FDA's own severity tier for the recall action — 25 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual.

Namespace context: the Class III index (25 records) and the recall hub (250 records, 118 FDA events); Water-jel Technologies, LLC (1 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0509-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0509-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-05-06
Ingested
2026-08-22
Record hash
d81300aa9a545c56

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.